WP
IART icon

Woodline Partners’s Integra LifeSciences IART Stock Holding History

Woodline Partners’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-110,770
Closed -$2.51M – 956
2024
Q4 		$2.51M Buy
+110,770
New +$2.42M 0.02% 619

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Woodline Partners's IART Position: Q1 2025 in Review

Woodline Partners sold out of Integra LifeSciences (IART) in Q1 2025, closing a stake of 110,770 shares — an estimated $2.51M sold.

Woodline Partners first reported a position in IART in Q4 2024 and held it in 1 quarter. The position peaked at $2.51M in Q4 2024. 219 funds tracked by Wall St. Rank hold IART as of Q1 2025.

  • Woodline Partners reported no remaining Integra LifeSciences position as of Q1 2025 after selling out during the quarter.
  • Woodline Partners sold 110,770 Integra LifeSciences shares in Q1 2025, an estimated $2.51M.
  • Woodline Partners first reported a position in Integra LifeSciences in Q4 2024 and held it in 1 quarter.
  • Woodline Partners's Integra LifeSciences position peaked at $2.51M in Q4 2024.
  • 219 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2025.

Based on Woodline Partners's 13F filing for Q1 2025, filed 15 May 2025.